Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
KRT10 antisense RNA 1 (KRT10-AS1) is a human long non-coding RNA gene, previously known as TMEM99 or transmembrane protein 99, located on chromosome 17[10][9][1]. This gene is predicted to produce a non-coding RNA that may be associated with membrane localization but does not encode a well-characterized or functional protein product[2][9]. The biological function remains unclear. Diseases associated with KRT10-AS1 include forms of epidermolytic hyperkeratosis and ichthyosis—these links are based on genomic location or transcript correlation but not on established functional causality[2]. There is no evidence to support its identification as a therapeutic target, receptor, enzyme, or transporter; its principal annotation is as a long non-coding RNA[2][10]. It has no known interacting drugs, defined mechanisms of action, established biomarker roles, or associated safety concerns.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on KRT10 antisense RNA 1 (KRT10-AS1).